ResearcherCancer Research UK Scotland InstituteNo recent work listed

Emily Jane Kay

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3398-0960; OpenAlex author ID A5013951943. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer. Co-author DOI 10.1002/1878-0261.13400 ↗
Two opposing sub-populations of fibroblasts decide progression of pancreatic cancer. Co-author DOI 10.1016/j.ccell.2021.07.022 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sara R. Zanivan · 2 shared papers, 2021–2023 · strength 0.67
- Paper Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer. DOI 10.1002/1878-0261.13400 ↗
- Paper Two opposing sub-populations of fibroblasts decide progression of pancreatic cancer. DOI 10.1016/j.ccell.2021.07.022 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.